PUBLICATIONS · 28453705
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2017 May 1
- First author
- Mato AR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Ann Oncol. 2017 May 1;28(5):920-921. doi: 10.1093/annonc/mdx103.
- note
- Source null
- related pmid
- 28379289
- relationship
- Comment in
Authors and identifiers
- name
- Mato AR
- type
- Author
- name
- Hill BT
- type
- Author
- name
- Lamanna N
- type
- Author
- name
- Barr PM
- type
- Author
- name
- Ujjani CS
- type
- Author
- name
- Brander DM
- type
- Author
- name
- Howlett C
- type
- Author
- name
- Skarbnik AP
- type
- Author
- name
- Cheson BD
- type
- Author
- name
- Zent CS
- type
- Author
- name
- Pu JJ
- type
- Author
- name
- Kiselev P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Mato AR
- type
- Author
- name
- Hill BT
- type
- Author
- name
- Lamanna N
- type
- Author
- name
- Barr PM
- type
- Author
- name
- Ujjani CS
- type
- Author
- name
- Brander DM
- type
- Author
- name
- Howlett C
- type
- Author
- name
- Skarbnik AP
- type
- Author
- name
- Cheson BD
- type
- Author
- name
- Zent CS
- type
- Author
- name
- Pu JJ
- type
- Author
- name
- Kiselev P
- type
- Author
- bibliography ids
- nci-bib-51e38ad831c17774c15d9b09
- book metadata
- content sha256
- 9b8b9a1525801e995ac2b305b5515f9d7b9562fa7f054f11889022ce2bbdd463
- document type
- citation
- dois
- 10.1093/annonc/mdx031
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28453705
- immutable id
- pubmed:28453705@9b8b9a1525801e995ac2b305b5515f9d7b9562fa7f054f11889022ce2bbdd463
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 5
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 1050-1056
- volume
- 28
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Ann Oncol. 2017 May 1;28(5):920-921. doi: 10.1093/annonc/mdx103.
- note
- Source null
- related pmid
- 28379289
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 28453705
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- cb0d84d9105a69a050633ef824c124294e8094cc41d8b4eacbbc5e4b7b259420
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017 May 1
- precision
- day
- year
- 2017
- publication types
- Journal Article
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
Preserved source evidence · Not medical advice
Triangle